AbbVie
Chicago, Illinois, United States
Anik Tuladhar, PhD, is a biomedical scientist with specialized expertise in preclinical musculoskeletal research, including rodent models, cartilage biology, and bone toxicity. His work integrates in vivo techniques—such as intra-articular injections and DMM surgery—with advanced histological, imaging, and molecular assays to evaluate skeletal remodeling and therapeutic interventions. He has led translational studies using human iPSC-derived models, 3D tissue culture, and AI-driven image analysis to assess drug effects on bone and cartilage. Anik has a strong record of collaboration across multidisciplinary teams and a passion for developing innovative models to advance therapeutic discovery in bone and joint diseases.
Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
